Bunch of nonsense, to say the least. If Timolol, with all the serious systemic issues related to heart and lungs could be approved, what makes you think that Rhopressa, which has a topical event related redness that eventually goes away by itself, wouldn't be approved? You better believe that both Rhopressa and Roclatan will get approved for sure! Don't fall for these crooked shorts!!!
Don't misrepresent the information. Please go read what AERI has publicly stated about how minor hyperemia is and how it went away within a few months by itself. Go back to your Inotek's board if you think it is so superior to AERI.
Every theme park roller coaster rider will soon be experiencing unbelievable virtual reality. Folks, VR is going to be a smash hit above and beyond anyone's expectations, and HIMX will be integral part of majority of the AR/VR sets. IMO, my HIMX shares are not for sale at least until 2020, when AR/VR market is expected to be $150 billion..